SE7409188L - Farmakologiskt aktiva foreningar. - Google Patents

Farmakologiskt aktiva foreningar.

Info

Publication number
SE7409188L
SE7409188L SE7409188A SE7409188A SE7409188L SE 7409188 L SE7409188 L SE 7409188L SE 7409188 A SE7409188 A SE 7409188A SE 7409188 A SE7409188 A SE 7409188A SE 7409188 L SE7409188 L SE 7409188L
Authority
SE
Sweden
Prior art keywords
pharmacologically active
active associations
methylthio
imidazolyl
bis
Prior art date
Application number
SE7409188A
Other languages
English (en)
Other versions
SE416202B (sv
Inventor
G J Durant
C R Ganellin
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of SE7409188L publication Critical patent/SE7409188L/sv
Publication of SE416202B publication Critical patent/SE416202B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/46Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7409188A 1973-07-13 1974-07-12 Forfarande for framstellning av foreningar vilka er antagonister mot vissa verkningar av histamin SE416202B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3342873A GB1431589A (en) 1973-07-13 1973-07-13 Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups

Publications (2)

Publication Number Publication Date
SE7409188L true SE7409188L (sv) 1975-01-14
SE416202B SE416202B (sv) 1980-12-08

Family

ID=10352834

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7409188A SE416202B (sv) 1973-07-13 1974-07-12 Forfarande for framstellning av foreningar vilka er antagonister mot vissa verkningar av histamin

Country Status (31)

Country Link
US (1) US4499101A (sv)
JP (1) JPS5830314B2 (sv)
AR (3) AR204928A1 (sv)
AT (1) AT346855B (sv)
BE (1) BE816850A (sv)
BG (1) BG25792A3 (sv)
CA (1) CA1049524A (sv)
CH (1) CH601252A5 (sv)
CS (1) CS199255B2 (sv)
DD (1) DD112449A5 (sv)
DE (1) DE2433625A1 (sv)
DK (1) DK334674A (sv)
EG (1) EG11259A (sv)
ES (3) ES428246A1 (sv)
FI (1) FI213274A (sv)
FR (1) FR2274298A1 (sv)
GB (1) GB1431589A (sv)
HU (1) HU169394B (sv)
IE (1) IE39607B1 (sv)
IL (1) IL45006A (sv)
IN (1) IN140943B (sv)
LU (1) LU70507A1 (sv)
MW (1) MW2674A1 (sv)
NL (1) NL7408942A (sv)
NO (1) NO143063C (sv)
OA (1) OA04814A (sv)
PH (1) PH11618A (sv)
PL (3) PL98705B1 (sv)
SE (1) SE416202B (sv)
SU (3) SU559647A3 (sv)
ZM (1) ZM10374A1 (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215125A (en) 1973-07-13 1980-07-29 Smith Kline & French Laboratories Limited Pyridyl ureas, thioureas and guanidines
US4062967A (en) * 1974-02-07 1977-12-13 Smith Kline & French Laboratories Limited Bis-guanidino-alkane compounds
US4151289A (en) 1975-01-22 1979-04-24 Smith Kline & French Laboratories Limited Nitromethylene amidino derivatives containing imidazole groups
GB1542840A (en) * 1975-02-03 1979-03-28 Smith Kline French Lab Heterocyclic dithiocarbamates and isothioureas
US4120972A (en) 1975-02-03 1978-10-17 Smith Kline & French Laboratories Limited Imidazolylmethylthio-ethyl isothiourea compounds
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
NZ186965A (en) 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
US4233302A (en) 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
US4309435A (en) 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
JPS5610175A (en) * 1979-07-06 1981-02-02 Fujisawa Pharmaceut Co Ltd Preparation of imidazole derivative
JPS5775975A (en) * 1980-08-27 1982-05-12 Glaxo Group Ltd Heterocyclic derivative, manufacture and medicinal composition containing same
EP0089153B1 (en) * 1982-03-17 1986-09-24 Smith Kline & French Laboratories Limited Pyridine derivatives
DE3512084A1 (de) * 1985-04-02 1986-10-09 Ludwig Heumann & Co GmbH, 8500 Nürnberg Guanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3579000D1 (de) 1985-04-02 1990-09-06 Heumann Pharma Gmbh & Co Imidazolylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DE3631334A1 (de) * 1986-09-15 1988-03-17 Heumann Pharma Gmbh & Co Neue imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
NL9100365A (nl) * 1991-02-27 1992-09-16 Seed Capital Investments Imidazoolderivaten met agonistische of antagonistische activiteit op de histamine h3-receptor.
AU662135B2 (en) * 1991-02-27 1995-08-24 Seed Capital Investments (Sci) B.V. Imidazole-derivatives having agonistic or antagonistic activity on the histamine H3-receptor
DK1032556T3 (da) * 1997-10-21 2008-03-25 Wyeth Corp Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
US7041702B1 (en) 1997-10-21 2006-05-09 Scion Pharmaceuticals, Inc. Pharmaceutically active compounds and methods of use
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL292485A (sv) * 1962-05-09
CH484918A (de) * 1965-10-28 1970-01-31 Ciba Geigy Verfahren zur Herstellung heterocyclischer, Aethylendoppelbindungen enthaltender Verbindungen
US3770755A (en) * 1967-09-26 1973-11-06 Ici Ltd 4-(4-bromophenyl)-2-(2-hydroxysopropyl) thiazole
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
US3868457A (en) * 1969-10-29 1975-02-25 Smith Kline French Lab Method of inhibiting histamine activity with guanidine compounds
US3749728A (en) * 1972-02-15 1973-07-31 Smith Kline French Lab N-cycloalkyl and n-cycloalkane-alkylthioamides
US3821229A (en) * 1972-12-07 1974-06-28 American Cyanamid Co Diquaternary salts of di-4-pyridyl ketone
US4013659A (en) * 1973-07-13 1977-03-22 Smith Kline & French Laboratories Limited Certain n,n'-disubstituted guanidine compounds and their use
US4156727A (en) * 1975-07-31 1979-05-29 Smith Kline & French Laboratories Limited Alkoxy pyridine compounds

Also Published As

Publication number Publication date
AU6984574A (en) 1975-12-11
ES437770A1 (es) 1977-01-16
NL7408942A (nl) 1975-01-15
JPS5830314B2 (ja) 1983-06-28
ES437769A1 (es) 1977-02-01
DK334674A (sv) 1975-03-03
FR2274298B1 (sv) 1978-07-21
JPS5032174A (sv) 1975-03-28
CS199255B2 (en) 1980-07-31
SU567405A3 (ru) 1977-07-30
NO742563L (sv) 1975-02-10
ATA552674A (de) 1978-04-15
US4499101A (en) 1985-02-12
AR202617A1 (es) 1975-06-24
SE416202B (sv) 1980-12-08
CH601252A5 (sv) 1978-06-30
IL45006A (en) 1978-07-31
CA1049524A (en) 1979-02-27
BG25792A3 (en) 1978-12-12
ZM10374A1 (en) 1975-04-21
PL98705B1 (pl) 1978-05-31
GB1431589A (en) 1976-04-07
FI213274A (sv) 1975-01-14
ES428246A1 (es) 1976-07-16
AR204928A1 (es) 1976-03-19
MW2674A1 (en) 1975-05-13
LU70507A1 (sv) 1974-11-28
NO143063B (no) 1980-09-01
IN140943B (sv) 1977-01-01
PH11618A (en) 1978-04-12
SU571193A3 (ru) 1977-08-30
HU169394B (sv) 1976-11-28
FR2274298A1 (fr) 1976-01-09
IE39607B1 (en) 1978-11-22
AT346855B (de) 1978-11-27
DE2433625A1 (de) 1975-01-30
IL45006A0 (en) 1974-09-10
OA04814A (fr) 1980-10-31
AR202618A1 (es) 1975-06-24
DD112449A5 (sv) 1975-04-12
NO143063C (no) 1980-12-10
PL96460B1 (pl) 1977-12-31
EG11259A (en) 1977-01-31
PL98609B1 (pl) 1978-05-31
SU559647A3 (ru) 1977-05-25
IE39607L (en) 1975-01-13
BE816850A (fr) 1974-12-27

Similar Documents

Publication Publication Date Title
SE7409188L (sv) Farmakologiskt aktiva foreningar.
ATE158288T1 (de) Antiatherosklerotische und antithrombotische 1- benzopyran-4-on- und 2-amino-1,3-benzoxazin-4-on- derivate
SE7505527L (sv) Substituerade fenylguanidiner och sett att framstella dessa.
AR221682A1 (es) Procedimiento para la preparacion de derivados de 2(imidazol-4-il,piridil-2-ilo o tiazolil-2-ilo-butil o metiltio-etilamino)-5-(1-naftil-alquilenoxi;1,3-benzodioxolil-alquilenoxi;1,4-benzodioxinilalquilenoxi;1-naftilalquilen;1,3-benzodioxolilalquilen;o 1,4-benzo dioxinilalquilen)-4-pirimidona o 4-pirimidintiona
IT7826742A0 (it) Impianto per il convogliamento pneumatico di materiali sfusi.
AR218242A1 (es) Procedimiento para la produccion de derivados de acidos n-(2-(imidazolil o tiazolil-metil-tio)-etil)-amidino formico
AT324902B (de) Am schuhvorderteil angreifendes, fangriemenartiges verbindungsglied
SE7908168L (sv) Cysteinderivat
RO70265A (ro) Procedeu pentru prepararea unor benzamide 2,5-substituite
AR210756A1 (es) Procedimiento para la preparacion de derivados de 2-4-(2-pirrolidin-1-iletoxi)anilino benzotiazol
OA04735A (fr) Procédé de préparation de N-arylsulfonyl N'-(aza-3 bicycloalkyl) urées.
PT86611A (pt) Process for the manufacture of n,n-(dibenzohexatrienylene)ureas
AR194249A1 (es) Procedimiento para la preparacion de n-(2,4-dihalogen-s-triacin-6-il)ureas
ES458756A1 (es) Procedimiento para preparar derivados de isotiourea.
DK139515B (da) Fremgangsmaade til fremstilling af n-(trans-4-hydroxycyckihexyl)-(2-amino-3,5-dibrombenzyl)-amin eller syreadditionssalte deraf
FR2310072A7 (fr) Agrafe pour la fixation de cables, petits tubes ou objets analogues
AR219897A1 (es) Procedimiento para la preparacion de 1-sustituido, 5-(fenil) sustituido)-3-metil-1,3,5-triazapenta-1,4-dieno
AR204072A1 (es) Procedimiento para la sintesis de derivados de 1-oxa-2-oxo-3,8-diazo-espiro-(4,5)-decano
AR206624A1 (es) Procedimiento para la preparacion de derivados de 1,2,6,7-tetrahidro-2-metil-1-(2-(metil o etil)-aminoetil)-indolo-(1,7-ab)(1)benzacepina
AR205352A1 (es) Procedimiento para la produccion de nuevas n'-(aminoacilaminofenil) - n,n-dimetil-acetamidinas
SE402277B (sv) Forfarande for framstellning av 4-amino-2,5-substituerade n-(dialkylaminoalkyl)bensamider genom reaktion med dialkylaminoalkylfosforamider
ES528900A0 (es) Procedimiento para la obtencion de n-(2-(1,2-dicloroviniloxi)-fenilsulfonil)-(tio) ureas
IT7920146A0 (it) Procedimento per la preparazione di derivati del tiazolo, particolarmente utili come medicamenti.
SU655680A1 (ru) Композици дл склеивани материалов
AR212235A1 (es) Procedimiento para la preparacion de imidas del acido 5-endo-(3-indolecarboniloxi)-n-(aminoquilo inferior)-biciclo(3.3.1)-heptano-2,3-di-endo-carboxilico

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7409188-5

Effective date: 19811019

Format of ref document f/p: F